I know. Everything was supposed to be so sure and de-risked.
Then, when they failed they just found the standard wording that all is part of a normal risk related to the biotech companies.
Too easy to ask for continuity after so many happenings. As a shareholder, I ask if it is normal what has happened to this Company, or issues have been forced to dig deeper as possible before all had to fail.
Ann: Shareholder Update, page-6
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
